Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).
Specialties
45 open remote positions
United States
Posted 4 days ago
United States
Posted 4 days ago
United States
Posted 5 days ago
United States
Posted 5 days ago
United States
Posted 5 days ago
United States
Posted 6 days ago
United States
Posted 6 days ago
United States
Posted 7 days ago
United States
Posted 7 days ago
United States
Posted 7 days ago
United States
Posted 7 days ago
Canada
Posted 7 days ago
United States
Posted 11 days ago
United States
Posted 11 days ago
United States
Posted 12 days ago
United States
Posted 13 days ago
United States
Posted 13 days ago
United States
Posted 13 days ago
United States
Posted 14 days ago
United States
Posted 17 days ago
United States
Posted 17 days ago